Reduced Risk Status: |
|
IPM Compatibility: |
Per Requester: Very Good Fit; Beauveria is non specific and dose dependent. No bee toxicity has been observed in preliminary hive treatments with high doses of Beuveria administered as a strip. No effect of hive health was observed with queens laying eggs and brood normal development. Commercial products are available with Beauveria for house fly and darkling beetle control in poultry houses. These products are used in the organic markets where insecticides are not allowed. For IPM programs, Beauveria can be used as a rotation product and due to being a biological, flexibility is use.
|
Reasons for need: |
Varroa destructor, The varroa mite is an external parasite that attacks and feeds on honey bees adults and brood. Additionally, the mite carries diseases into the hives. A significant mite infestation results in the death of the hive. The economic threshold is considered to be around 3 to 5%, 3 to 5 mites per 100 bees.Resistance to chemical active ingredients leaves the beekeeper with few control options. Rotation to non chemical alternative provides the beekeeper with control options. Beauveria's mode of action of cuticle destruction allows for resistance to be difficult. Biological actives are also exempt from tolerance allowing flexibility is treatment:07/24;
|
Requesting State(s): |
IN:Hack, R* ;
|
PCR Use Pattern: |
Apply 2-4 times a year, every 2-4 weeks.
|
EPA Default Residue Trials: |
|
IR-4 Residue Trial Plan: |
|
Residue Protocol Use Pattern: |
|
Efficacy/Crop Safety (E/CS) Data Required: |
|
E/CS Research Comments: |
|
Label Use Pattern Submitted To EPA: |
|
EPA PIF Status: |
|
EPA Status: |
|
EPA PRIA Date: |
|
MRID: |
|
Comments: |
The mfg, JABB, is working to finalize a formulation and use pattern and plan to provide an update before the '24 workshop:08/24/sb;
|
International Status: |
|
Archive Location: |
|
QA Archive: |
|